Top Funds / PERCEPTIVE ADVISORS LLC


Joseph Edelman

2016Q3 Portfolio

SEC 13F Filing

Position #Shares $Value % # vs. 2016Q2 $ vs. 2016Q2
Achillion Pharmaceuticals Inc ON STOCK 929,290 $7,527,000 0.49% New +$7,527,000
Akebia Therapeutics, Inc. ON STOCK 809,096 $7,295,000 0.47% New +$7,295,000
DYNAVAX TECHNOLOGIES CORP US EQUITY OPTION PUT 16,000 $7,180,000 0.46% New +$7,180,000
NEPTUNE TECHNOLOGIES AND BIORESOURCES ON STOCK 6,750,444 $7,155,000 0.46% New +$7,155,000
AGILE THERAPEUTICS INC ON STOCK 1,020,011 $7,120,000 0.46% New +$7,120,000
AGENUS INC ON STOCK 900,000 $6,462,000 0.42% New +$6,462,000
CAPITAL SENIOR LIVING CORP ON STOCK 375,306 $6,305,000 0.41% New +$6,305,000
ARROWHEAD PHARMACEUTICALS, INC. ON STOCK 847,458 $6,228,000 0.40% New +$6,228,000
Clovis Oncology, Inc. ON STOCK 171,500 $6,183,000 0.40% New +$6,183,000
Xenon Pharmaceuticals Inc. ON STOCK 762,800 $6,179,000 0.40% New +$6,179,000
SUPERNUS PHARMACEUTICALS, INC. ON STOCK 244,550 $6,048,000 0.39% New +$6,048,000
HISTOGENCIS CORP ON STOCK 1,777,777 $5,706,000 0.37% New +$5,706,000
ASSEMBLY BIOSCIENCES, INC. ON STOCK 777,669 $5,606,000 0.36% New +$5,606,000
Cascadian Therapeutics, Inc. ON STOCK 3,414,121 $5,599,000 0.36% New +$5,599,000
PROTEOSTASIS THERAPEUTICS, INC. ON STOCK 344,550 $5,372,000 0.35% New +$5,372,000
ADMA BIOLOGICS, INC. ON STOCK 734,793 $5,327,000 0.34% New +$5,327,000
ONCOBIOLOGICS INC ON STOCK 1,248,990 $5,308,000 0.34% New +$5,308,000
AMARIN CORP PLC\UK DEPOSITORY RECEIPT 1,622,280 $5,175,000 0.33% New +$5,175,000
SELECTA BIOSCIENCES INC ON STOCK 348,150 $4,961,000 0.32% New +$4,961,000
NEURODERM LTD ON STOCK 264,114 $4,883,000 0.32% New +$4,883,000
Anthera Pharmaceuticals Inc ON STOCK 1,459,627 $4,598,000 0.30% New +$4,598,000
Cellectis S.A. DEPOSITORY RECEIPT 179,506 $4,323,000 0.28% New +$4,323,000
CEMPRA INC ON STOCK 175,503 $4,247,000 0.27% New +$4,247,000
APPLIED GENETIC TECHNOLOGIES CORP ON STOCK 426,048 $4,167,000 0.27% New +$4,167,000
ABEONA THERAPEUTICS INC. WARRANTS 1,259,636 $4,093,000 0.26% New +$4,093,000